Janice Q Hung, OD
Optometrist · West Covina
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hung’s office at (626) 461-7300 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$3,883
Medicare paid this office $3,883 for 38 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 20 | $1,684 | $77 |
| Established patient problem focused exam of visual system | 14 | $947 | $63 |
Who their Medicare patients are
38 Original Medicare patients in 2024. Average age 74 · Women 61% · Also on Medicaid 68% · Health risk score 1.64. Sicker patients than 9 in 10 peers; the typical optometry clinician is at 0.97.
Conditions among them: High blood pressure 74% · Diabetes 58% · Chronic kidney disease 34%.
The office billed $13,088, Medicare allowed $6,326 and paid $3,883; for 55 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 38 | 55 | 74 | 1.64 | $13,088 | $3,883 |
| 2023 | 57 | 85 | 70 | 1.28 | $21,618 | $7,050 |
| 2022 | 45 | 63 | 72 | 1.18 | $17,980 | $5,424 |
| 2021 | 44 | 69 | 70 | 1.38 | $17,941 | $6,080 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Established patient complete exam of visual system | 24 | $2,809 | $100 |
| New patient complete exam of visual system | 13 | $1,528 | $118 |
| Established patient problem focused exam of visual system | 14 | $1,194 | $75 |
2022: 2 services
| Established patient complete exam of visual system | 14 | $1,479 | $99 |
| Established patient problem focused exam of visual system | 16 | $1,355 | $68 |
2021: 3 services
| Established patient complete exam of visual system | 13 | $1,496 | $115 |
| Established patient problem focused exam of visual system | 13 | $1,310 | $82 |
| Short return visit (20+ min) | 14 | $1,136 | $67 |
Medicaid work
$1,636 in 2024
Medicaid paid $1,636 for 1,701 billed services this clinician did in 2024, up to 72 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 230 | $398 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 137 | $324 |
| Frames, purchases | 347 | $269 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 222 | $248 |
| DETERMINATION REFRACTIVE STATE | 432 | $179 |
| Fitting of bifocal spectacles | 151 | $123 |
| Fitting of monofocal spectacles | 182 | $94 |
| 2024 | 1,701 | 7 | 72 | $1,636 |
| 2023 | 1,178 | 7 | 61 | $4,059 |
| 2022 | 213 | 2 | 25 | $1,580 |
| 2021 | 24 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 184 | $1,699 |
| DETERMINATION REFRACTIVE STATE | 408 | $963 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 109 | $605 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 160 | $540 |
| Frames, purchases | 156 | $144 |
| Fitting of monofocal spectacles | 87 | $60 |
| Fitting of bifocal spectacles | 74 | $47 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 47 | $896 |
| DETERMINATION REFRACTIVE STATE | 166 | $684 |
2021
| DETERMINATION REFRACTIVE STATE | 24 | $0 |
Drugs they prescribed that Part D paid
$70,074
Pharmacies billed $70,074 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 653) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
392 generic and 261 brand-name prescriptions · $70,074 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 35 | $30,816 | $880 |
| Xiidra | 22 | $20,834 | $947 |
| Lumigan | 16 | $5,722 | $358 |
| Latanoprost | 261 | $3,192 | $12 |
| Timolol Maleate | 98 | $1,070 | $11 |
See all 10 drugs
| Restasis | 35 | $30,816 | $880 |
| Xiidra | 22 | $20,834 | $947 |
| Lumigan | 16 | $5,722 | $358 |
| Latanoprost | 261 | $3,192 | $12 |
| Timolol Maleate | 98 | $1,070 | $11 |
| Dorzolamide-Timolol | 48 | $814 | $17 |
| Brimonidine | 65 | $774 | $12 |
| Ketorolac Tromethamine | 24 | $714 | $30 |
| Prednisolone Acetate | 16 | $423 | $26 |
| Neomycin-Polymyxin-Dexameth | 12 | $145 | $12 |
Year by year
| 2024 | 653 | 170 | 0% (0) | 40% | $70,074 |
| 2023 | 585 | 180 | 0% (0) | 47% | $64,566 |
| 2022 | 649 | 209 | 0% (0) | 39% | $56,483 |
| 2021 | 422 | 149 | 0% (0) | 48% | $49,723 |
| 2020 | 15 | 11 | 0% (0) | None | $2,653 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Restasis | 18 | $18,795 | $1,044 |
| Xiidra | 14 | $17,779 | $1,270 |
| Latanoprost | 275 | $6,186 | $22 |
| Lumigan | 11 | $4,217 | $383 |
| Timolol Maleate | 70 | $2,121 | $30 |
| Brimonidine | 49 | $1,944 | $40 |
| Dorzolamide-Timolol | 54 | $1,301 | $24 |
| Ketorolac Tromethamine | 13 | $298 | $23 |
2022: 8 drugs
| Restasis | 16 | $17,545 | $1,097 |
| Latanoprost | 306 | $8,015 | $26 |
| Brimonidine | 33 | $2,404 | $73 |
| Dorzolamide-Timolol | 84 | $2,253 | $27 |
| Timolol Maleate | 83 | $1,445 | $17 |
| Dorzolamide | 31 | $1,296 | $42 |
| Prednisolone Acetate | 18 | $803 | $45 |
| Ofloxacin | 12 | $111 | $9 |
2021: 8 drugs
| Restasis | 19 | $21,337 | $1,123 |
| Combigan | 24 | $5,886 | $245 |
| Latanoprost | 182 | $5,843 | $32 |
| Brimonidine | 44 | $4,263 | $97 |
| Dorzolamide-Timolol | 33 | $1,246 | $38 |
| Dorzolamide | 19 | $763 | $40 |
| Prednisolone Acetate | 12 | $671 | $56 |
| Timolol Maleate | 44 | $578 | $13 |
Money from drug and device companies
$90 in 2023
A payment is not proof that care is biased.
| Apellis Pharmaceuticals | None | $90 | 1 payment
|
See the published payment
| Apellis Pharmaceuticals | Meals · 2023-08-15 | None | $90 |
Professional record
- NPI
- 1750917936
- Licence
- CA 34296TLG
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 3658 S Nogales St, West Covina, CA, 91792
- NPI first listed
- 2020-03-19
- NPI last updated
- 2024-08-28
- NPI record certified
- 2024-08-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave Bldg 5, Palo Alto, CA, 94304 · 160 E Artesia St Ste 120, Pomona, CA, 91767 · 17833 Colima Road, Rowland Heights, CA, 91748